Allosteric modulators of the AMPA receptor: novel 6-substituted dihydrophthalazines.

[1]  K. A. Jones,et al.  Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor. , 1996, Journal of medicinal chemistry.

[2]  T. Stone.  CNS Neurotransmitters and Neuromodulators: Glutamate , 1995 .

[3]  J. E. Huettner,et al.  Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines. , 1995, Molecular pharmacology.

[4]  D. Attwell,et al.  Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms , 1994, Trends in Neurosciences.

[5]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[6]  R. McBurney.  Therapeutic potential of NMDA antagonists in neurodegenerative diseases , 1994, Neurobiology of Aging.

[7]  J. Olney.  Excitatory transmitter neurotoxicity , 1994, Neurobiology of Aging.

[8]  R. Schwarcz,et al.  Enzyme-activated antagonists of the strychnine-insensitive glycine/NMDA receptor. , 1994, Journal of medicinal chemistry.

[9]  F. Menniti,et al.  A short synthesis of GYKI 52466 , 1993 .

[10]  M. Rogawski,et al.  Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. , 1993, Trends in pharmacological sciences.

[11]  B. Meldrum.  Amino acids as dietary excitotoxins: A contribution to understanding neurodegenerative disorders , 1993, Brain Research Reviews.

[12]  M. Rogawski,et al.  GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses , 1993, Neuron.

[13]  D. Comins,et al.  Ortho substitution of m-anisaldehyde via .alpha.-amino alkoxide directed lithiation , 1989 .

[14]  D. Choi,et al.  Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.

[15]  B. Meldrum.  Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. , 1985, Clinical science.

[16]  P. Skolnick,et al.  Direct and allosteric control of glutamate receptors , 1994 .

[17]  P. Leeson,et al.  Anticonvulsant activity of glycine-site NMDA antagonists: 1. 2-Carboxyl prodrugs of 5,7-dichlorokynurenic acid , 1993 .